Neutropenia Agranulocytosis

71 slides · PPTX & PDF available

Download PDF

Request PowerPoint

PowerPoint animations are preserved in the original file.

Slide index (71)

Loading slide titles…

Loading presentation…

Swipe on touchscreens · Use ← / → to change slides, Home / End to jump.

Lecture topics

White-cell disorders: The immediate context
The cell-lineage pattern is a diagnostic clue
Autoimmune disease can cause neutropenia
Drug-associated examples
Three marrow patterns with one blood finding
The clinical syndrome is often infection driven
Case: Autoimmunity and isolated neutrophil loss
Primary reference

Slide index & full transcript (71 slides)

Text from the original slides, in presentation order. Diagrams and images remain in the viewer above.

Slide 1 · Neutropenia and

Agranulocytosis

Mechanisms, marrow morphology, and infectious consequences

An integrated clinicopathologic teaching lecture

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Differentiate leukopenia, neutropenia, and agranulocytosis.

Classify neutropenia by failure of marrow production versus peripheral loss.

Relate bone-marrow patterns to the underlying mechanisms.

Recognize infection patterns and the urgency of severe neutropenia.

Slide 3 · White-cell disorders: The immediate context

Proliferative disorders

Leukopenic disorders

Expansion of circulating or tissue leukocytes

Deficiency of circulating white cells

May be reactive or neoplastic

Most commonly reflects reduced neutrophils

Reactive increase often accompanies infection/inflammation

Reduced granulocytes impair the host response to infection

The lecture focuses on the leukopenic arm of white-cell pathology.

Slide 4 · Leukopenia is not synonymous with neutropenia

Leukopenia refers to a reduced total circulating white-cell count.

Neutropenia designates a reduction in circulating neutrophils.

Neutrophil loss is the most common explanation for leukopenia.

Lymphopenia is a separate, less common explanation for leukopenia.

LEUKOPENIA

Reduced neutrophils

Reduced lymphocytes

Schematic

Slide 5 · Lymphopenia provides a useful contrast

Lymphopenia with immunodeficiency, advanced HIV infection, and several acquired disorders.

Glucocorticoids, cytotoxic drugs, autoimmune disorders, and malnutrition can be associated with lymphopenia.

Acute viral infection can redistribute T cells into lymph nodes and vascular compartments.

The pathogenesis of neutropenia instead centers on granulopoiesis and peripheral neutrophil loss.

Slide 6 · Neutrophils are essential antimicrobial effectors

A severe reduction in circulating neutrophils compromises defense against bacteria and fungi.

Organisms can proliferate extensively when leukocyte recruitment is inadequate.

The lesion may contain abundant microorganisms but little inflammatory-cell response.

Neutrophil deficiency

Weak local leukocyte response

Invasive infection

Schematic

Slide 7 · Agranulocytosis represents profound neutrophil depletion

Agranulocytosis denotes an extreme reduction in blood neutrophils.

The resulting susceptibility to serious bacterial and fungal infections is central to its clinical importance.

It is a severe neutropenic state, not a separate leukocyte lineage disorder.

The term describes severity; The cause still requires investigation.

Slide 8 · Two major pathogenetic pathways

Reduced or ineffective marrow output OR peripheral loss

Low circulating neutrophil pool

Infection susceptibility

Both inadequate granulopoiesis and peripheral destruction or sequestration can lead to the same severe clinical consequence.

Editable mechanism schematic

Slide 9 · Production failure versus peripheral loss

Defective marrow output

Accelerated peripheral loss

Stem-cell or precursor suppression

Immune destruction of mature neutrophils

Ineffective granulopoiesis

Splenic sequestration/destruction

Congenital differentiation defects

Increased utilization during overwhelming infection

Marrow may be hypocellular OR hypercellular

Marrow often compensates by increasing granulopoiesis

The marrow response depends on which biologic step is disrupted.

Slide 10 · Normal granulopoiesis is a multistep process

Hematopoietic stem cells generate committed granulocytic progenitors.

Granulocytic precursors differentiate within marrow before mature neutrophils are released.

Interruption can occur at the stem-cell, precursor, or maturation stage.

The stage of interruption helps explain the associated cytopenias.

Stem-cell compartment

Granulocytic precursor

Circulating neutrophil

Schematic

Slide 11 · Stem-cell suppression reduces several blood lineages

Aplastic anemia exemplifies suppression of hematopoietic stem cells.

Neutropenia is accompanied by anemia and thrombocytopenia when stem-cell output is broadly impaired.

The combined cytopenia pattern distinguishes generalized failure from an isolated neutrophil disorder.

HSC suppression

Reduced granulocytes + RBCs

Reduced platelets

Schematic

Slide 12 · Marrow infiltration also compromises hematopoiesis

Tumors and granulomatous disease can occupy or disrupt the marrow compartment.

Impaired hematopoietic output may affect granulocytes as well as red cells and platelets.

A low neutrophil count with other cytopenias should raise suspicion of a shared marrow lesion.

Marrow infiltration

Granulocyte deficiency

Other cytopenias

Schematic

Slide 13 · The cell-lineage pattern is a diagnostic clue

Blood-count pattern

Mechanistic implication

Neutropenia with anemia and thrombocytopenia

Consider broad marrow suppression or infiltrative disease

Predominantly neutropenia

Consider selective precursor toxicity, immune loss, or other granulocyte-specific pathways

Neutropenia with thrombocytopenia and splenomegaly

Consider splenic sequestration among the causes

These patterns guide reasoning but are not standalone diagnoses.

Slide 14 · Committed granulocytic precursors can be targeted

Some drugs preferentially suppress granulocyte precursors in marrow.

Reduced maturation lowers neutrophil supply into the circulation.

The pattern differs from generalized hematopoietic suppression, which affects multiple cell lines.

A drug history becomes mechanistically relevant even when other counts are less affected.

Precursor-toxic exposure

Reduced granulocyte output

Neutropenia

Schematic

Slide 15 · Ineffective granulopoiesis: Production without output

Granulocytic precursors may be generated yet fail to survive and mature normally.

Defective precursors die within the marrow compartment.

The marrow can be hypercellular despite diminished circulating neutrophils.

Cellularity alone therefore does not establish effective neutrophil production.

Precursor proliferation

Intramedullary cell death

Low blood neutrophils

Schematic

Slide 16 · Megaloblastic anemia exemplifies ineffective output

Megaloblastic anemia is a disease state associated with ineffective hematopoiesis.

Defective hematopoietic precursors die in the marrow.

Neutropenia can coexist with a cellular marrow rather than marrow aplasia.

Interpret the neutrophil count together with the broader hematologic pattern.

Bone marrow • schematic

Cellular marrow ≠ effective granulopoiesis

Cell-symbol diagram; Not histology

Slide 17 · Myelodysplastic neoplasms also impair output

Myelodysplastic neoplasms can produce neutropenia through ineffective granulopoiesis.

The marrow may be hypercellular because precursor production persists.

Ineffective maturation reduces the number of functional mature cells reaching blood.

The key distinction is ineffective production, not accelerated peripheral removal.

Bone marrow • schematic

Ineffective marrow production

Cell-symbol diagram; Not histology

Slide 18 · Congenital neutropenia involves differentiation

Rare inherited defects impair granulocytic differentiation.

Severe congenital neutropenia (Kostmann syndrome) is one example.

The essential defect acts during maturation of granulocytic cells.

The clinical phenotype is reduced availability of mature circulating neutrophils.

Inherited gene defect

Impaired differentiation

Severe neutropenia

Schematic

Slide 19 · Production-side mechanisms are not equivalent

Mechanism

Example

Expected interpretation

Stem-cell suppression

Aplastic anemia

Broad hematopoietic deficit

Marrow replacement

Tumor / granulomatous disease

Multiple lineages may fall

Ineffective hematopoiesis

Megaloblastic anemia / MDS

Cellular marrow with poor effective output

Differentiation defect

Severe congenital neutropenia

Impaired granulocytic maturation

MDS = myelodysplastic neoplasm.

Slide 20 · Peripheral neutrophil depletion has three routes

Immune-mediated injury can destroy mature neutrophils.

An enlarged spleen can increase sequestration and macrophage-mediated removal.

Overwhelming infections can increase peripheral neutrophil utilization.

In each route, peripheral demand or loss may outpace effective replacement.

Peripheral neutrophil loss

Immune injury

Splenic sequestration

Infection-related use

Schematic

Slide 21 · Immune-mediated neutrophil destruction

Antineutrophil immune responses can increase peripheral neutrophil loss.

The process may be idiopathic, associated with an autoimmune disorder, or drug-related.

Marrow precursors may respond to peripheral loss by increasing granulopoiesis.

The peripheral count and the marrow cellularity can therefore diverge.

Immune injury

Accelerated neutrophil loss

Compensatory marrow activity

Schematic

Slide 22 · Autoimmune disease can cause neutropenia

Systemic lupus erythematosus is an example of an immune disorder associated with neutrophil injury.

The pathogenic category is peripheral immune destruction rather than intrinsic precursor maturation failure.

Association with systemic autoimmunity helps place neutropenia in its clinical context.

Slide 23 · Acquired idiopathic neutropenia may be antibody mediated

Some patients have antibodies directed against neutrophil-specific antigens.

These autoantibodies accelerate destruction of circulating neutrophils.

The presence of an immune mechanism does not imply malignant marrow replacement.

An appropriate compensatory marrow response may be retained.

Neutrophil-targeting antibody

Peripheral destruction

Reduced circulating count

Schematic

Slide 24 · Splenomegaly increases neutrophil sequestration

An enlarged spleen contains increased numbers and activity of macrophages.

Sequestration and destruction of neutrophils can cause modest neutropenia.

Thrombocytopenia is often associated; Anemia may also occur.

The concurrence of splenomegaly and cytopenias supports a sequestration mechanism.

Splenic enlargement

Macrophage sequestration / loss

Modest neutropenia

Schematic

Slide 25 · Splenic sequestration: Pattern recognition

Finding

Mechanistic interpretation

Enlarged spleen

Increased splenic cell pooling and macrophage activity

Modest neutropenia

Enhanced removal of circulating neutrophils

Thrombocytopenia, sometimes anemia

Multiple blood-cell lineages may be sequestered

The source describes this pattern, not a diagnostic numerical algorithm.

Slide 26 · Overwhelming infection can consume neutrophils

Severe bacterial, fungal, or rickettsial infection can increase peripheral utilization.

Neutrophil consumption may become disproportionate to marrow replacement.

Thus infection may be both a consequence and a cause of neutropenia.

The direction of causation must be interpreted in clinical context.

Severe infection

Increased utilization

Neutropenia

Conceptual sequence

Slide 27 · Peripheral mechanisms compared

Immune

Splenic

Infection-associated

Antibody/immune injury

Macrophage pooling and destruction

Accelerated utilization

May be idiopathic, SLE-related, or drug-related

Typically accompanied by splenomegaly

Overwhelming bacterial, fungal, or rickettsial disease

Marrow compensation possible

Often modest neutropenia

Neutropenia can amplify subsequent infection

Slide 28 · Drug toxicity is central to agranulocytosis

Drug toxicity as the most common cause of agranulocytosis.

Drugs can suppress marrow cell production or promote immune neutrophil destruction.

Distinguishing predictable marrow toxicity from idiosyncratic reactions clarifies the mechanism.

The medication exposure history is therefore essential to causal interpretation.

Drug-induced agranulocytosis

Predictable, dose-related

Idiosyncratic reaction

Schematic

Slide 29 · Cytotoxic drugs can cause predictable suppression

Alkylating agents and antimetabolites are examples used in cancer treatment.

Agranulocytosis may develop in a predictable, dose-related fashion.

Their effects can suppress hematopoiesis beyond the granulocytic lineage.

Red-cell and platelet production may also be compromised.

Myelosuppressive chemotherapy

Multilineage marrow suppression

Neutropenia + other cytopenias

Schematic

Slide 30 · Generalized drug toxicity affects three lineages

Neutrophil production declines when granulocytic progenitors are injured.

Concurrent effects on erythropoiesis and megakaryopoiesis explain anemia and thrombocytopenia.

Multilineage involvement favors generalized hematopoietic suppression.

The underlying mechanism should not be misclassified as isolated peripheral immune destruction.

Global myelosuppression

Reduced neutrophils

Reduced red cells

Reduced platelets

Schematic

Slide 31 · Idiosyncratic drug reactions are less predictable

Agranulocytosis can occur as an idiosyncratic response to diverse medications.

Certain antibiotics, anticonvulsants, anti-inflammatory agents, antipsychotics, and diuretics.

A drug class does not determine a unique mechanism for every patient.

The marrow-targeting and antibody-mediated pathways should be distinguished.

Slide 32 · Drug-associated examples

Exposure group

Source-described association

Alkylating agents; Antimetabolites

Predictable, dose-related myelosuppression

Chlorpromazine / related phenothiazines

Toxic effect on granulocytic precursors

Sulfonamides

Probably antibody-mediated neutrophil destruction

Selected antibiotics, anticonvulsants, anti-inflammatory drugs, diuretics

Idiosyncratic agranulocytosis may occur

Categories and examples are not exhaustive; No relative-risk ranking is supplied.

Slide 33 · Phenothiazines can injure marrow precursors

Chlorpromazine and related phenothiazines are antipsychotic drug examples.

Their associated neutropenia is described as a toxic effect on granulocytic precursors.

The mechanistic injury occurs before mature neutrophil release.

Marrow suppression can explain the diminished blood neutrophil count.

Phenothiazine exposure

Granulocytic precursor toxicity

Reduced neutrophil output

Schematic

Slide 34 · Sulfonamide reactions suggest immune destruction

An antibody-mediated mechanism for agranulocytosis following sulfonamides.

The analogy is to drug-induced immunohemolytic anemia.

The word “probably” matters: The source expresses mechanistic uncertainty.

Peripheral immune injury differs biologically from direct marrow precursor toxicity.

Sulfonamide exposure

Probable immune injury

Peripheral neutrophil loss

Schematic

Slide 35 · Two drug mechanisms predict different marrow states

Precursor toxicity

Peripheral immune destruction

Inhibits or destroys developing granulocytes

Targets circulating mature neutrophils

Reduced marrow output

Marrow may increase compensatory production

Hypocellularity when precursors are suppressed

Hypercellular marrow may be observed

Example: Phenothiazine mechanism

Example: Proposed sulfonamide mechanism

Patterns are mechanism-based expectations, not drug-specific biopsy rules.

Slide 36 · Large granular lymphocyte proliferations

Severe neutropenia may accompany monoclonal proliferations of large granular lymphocytes.

Robbins refers to this association as large granular lymphocyte (LGL) leukemia.

The neoplastic population is usually a CD8-positive cytotoxic T-cell population.

Recognition of the association broadens the differential beyond drugs and autoimmunity.

LGL proliferation

Usually CD8+ T cells

Severe neutropenia

Schematic

Slide 37 · The LGL mechanism remains incompletely defined

The mechanism of associated neutropenia is unclear.

Suppression of granulocytic progenitors by neoplastic-cell products is considered most likely.

Do not present this proposed pathway as a proven universal mechanism.

Its inferred site of action is granulocytic production rather than simple splenic pooling.

LGL neoplastic cells

Proposed progenitor suppression

Severe neutropenia

Schematic

Slide 38 · Marrow cellularity is a mechanistic readout

Low peripheral neutrophil count

Review marrow cellularity

Identify mechanism and associated cytopenias

Hypercellularity can reflect compensation OR ineffective hematopoiesis; Hypocellularity supports suppression of precursors.

Editable mechanism schematic

Slide 39 · Peripheral destruction usually stimulates marrow

When mature neutrophils are removed in the periphery, granulocytic precursors can expand.

The marrow as usually hypercellular in excessive peripheral destruction.

The expanded marrow compartment is compensatory rather than evidence of adequate blood counts.

Blood and marrow compartments must be interpreted separately.

Bone marrow • schematic

Compensatory granulocytic expansion

Cell-symbol diagram; Not histology

Slide 40 · Ineffective granulopoiesis can also be hypercellular

Megaloblastic anemia and myelodysplastic neoplasms commonly show marrow hypercellularity.

Here the abundant precursors do not mature effectively into circulating neutrophils.

Premature death of defective precursors accounts for impaired net output.

The same marrow cellularity can therefore have a different underlying explanation.

Bone marrow • schematic

Many precursors; Poor effective output

Cell-symbol diagram; Not histology

Slide 41 · Precursor-suppressing agents may cause hypocellularity

Drug injury that suppresses or destroys granulocyte precursors reduces the developing-cell pool.

Precursor-toxic agranulocytosis with marrow hypocellularity.

This pattern contrasts with the hypercellular response to peripheral destruction.

It also contrasts with the hypercellular but ineffective production of some marrow diseases.

Bone marrow • schematic

Suppressed developing granulocytes

Cell-symbol diagram; Not histology

Slide 42 · Three marrow patterns with one blood finding

Peripheral destruction

Ineffective granulopoiesis

Precursor suppression

Marrow often hypercellular

Marrow may be hypocellular

Compensatory production

Precursors die or fail to mature

Precursor pool reduced

Neutrophils lost after release

Effective output diminished

Production capacity diminished

Interpret cellularity together with lineage composition and history.

Slide 43 · Why marrow hypercellularity does not exclude neutropenia

The peripheral count reflects successful release and survival of mature neutrophils.

A cellular marrow may represent unsuccessful precursor maturation.

It may alternatively reflect an appropriate response to peripheral destruction.

Thus high marrow cellularity and low blood neutrophils are not contradictory.

High marrow cellularity

Low effective output

Neutropenia

Conceptual sequence

Slide 44 · Biopsy interpretation requires a clinicopathologic link

Bone-marrow cellularity alone does not specify the diagnosis.

Ask whether granulocytic cells are suppressed, ineffective, or compensating for peripheral loss.

Assess whether red cells and platelets are also deficient.

Integrate marrow observations with drug exposure, immune disease, infection, and splenomegaly.

Slide 45 · Neutropenia changes the appearance of infection

Infections can contain large burdens of bacteria or fungi.

Sites of infection may show little leukocytic response despite extensive microbial growth.

The paucity of inflammatory cells reflects impaired neutrophil availability.

A muted local cellular response does not indicate a harmless lesion.

Few circulating neutrophils

Little leukocytic infiltrate

Extensive microbial growth

Schematic

Slide 46 · Necrotizing oral lesions are characteristic

Agranulocytosis may produce necrotizing ulcerative lesions in the oral cavity.

Frequent sites include gingiva, mouth floor, buccal mucosa, and pharynx.

Ulcers are described as deep and undermined.

Severe infection and impaired local inflammatory response contribute to the destructive morphology.

Sites

Gingiva

Floor of mouth

Buccal mucosa

Pharynx

Anatomic labels • not clinical images

Slide 47 · The surface of oral ulcers may be necrotic

Gray to green-black necrotic membranes covering characteristic ulcers.

Bacteria or fungi can be recovered from these membranes.

The combination of deep tissue damage and microbial overgrowth signals substantial local infection.

No synthetic photomicrograph is substituted for authentic clinical-pathology evidence.

Slide 48 · Other mucocutaneous sites may be affected

Similar necrotizing ulcerative lesions occur less often outside the oral cavity.

Documented sites include skin, vagina, and anus.

Lesions can also occur along the gastrointestinal tract.

Their distribution reflects vulnerability to infection when neutrophil-mediated defense is lost.

Sites

Skin

Anus

Vagina

Gastrointestinal tract

Anatomic labels • not clinical images

Slide 49 · Deep infections extend beyond mucosal surfaces

Severe invasive bacterial or fungal infections can involve the lungs.

The urinary tract and kidneys are additional reported sites.

Invasiveness and rapid progression become major clinical concerns in profound neutropenia.

Organism proliferation may be disproportionate to the visible leukocytic response.

Severe infection

Lungs

Urinary tract

Kidneys

Schematic

Slide 50 · Candida and Aspergillus are key fungal threats

Deep infections due to Candida species in neutropenic patients.

Aspergillus is another important fungal threat in this setting.

Both are examples of invasive fungal disease associated with profound neutrophil deficit.

Organism identity and tissue invasion require genuine microbiologic or pathologic evidence.

Neutropenic host

Candida infection

Aspergillus infection

Schematic

Slide 51 · Organ-site complications

Site

Source-described implication

Oral mucosa

Deep undermined necrotizing ulcers

Skin / vagina / anus / GI tract

Less frequent ulcerative lesions

Lung

Potential life-threatening invasive infection

Urinary tract / kidney

Potential severe bacterial or fungal infection

Slide 52 · The clinical syndrome is often infection driven

Symptoms may include malaise, chills, and fever.

Marked weakness and fatigability can follow.

The severity depends strongly on the consequences of infection.

Agranulocytosis can permit overwhelming, rapidly progressive infectious disease.

Slide 53 · Infection may become fulminant in agranulocytosis

The host may be unable to mount an adequate neutrophilic response.

Bacterial or fungal growth can progress rapidly despite little local leukocyte infiltration.

Overwhelming infections may be fatal within hours to days.

Fever or new infectious symptoms in a severely neutropenic patient require immediate attention.

Profound neutropenia

Impaired microbial control

Rapid invasive infection

Schematic

Slide 54 · Risk rises sharply with severe count reduction

Neutrophil counts below 500 per mm³ as especially associated with serious infection.

The count is a marker of host-defense capacity, not a stand-alone diagnosis.

The clinical trajectory and suspected infection site are essential alongside the count.

Profound agranulocytosis denotes an even more severe neutrophil deficit.

< 500/mm³

Serious infection becomes particularly likely

Threshold cited

Slide 55 · Why the peripheral blood count matters

Blood neutrophils form an accessible marker of the host’s antimicrobial defense.

Loss of these cells compromises the cellular response at infected tissues.

Very low counts correlate with potentially invasive, high-burden infection.

Quantitative deficiency must be interpreted with the relevant clinical symptoms.

Blood neutrophils fall

Tissue recruitment impaired

Bacterial / fungal risk rises

Schematic

Slide 56 · Prompt treatment is an emergency principle

Expeditious broad-spectrum antibiotic therapy when infectious signs or symptoms occur.

Treatment urgency follows the potential for fulminant infection.

The immediate clinical priority is infection control while the neutropenia mechanism is assessed.

This lecture addresses the principle, not a regimen or dosing protocol.

Infectious symptoms

Immediate clinical evaluation

Expeditious antimicrobial treatment

Schematic

Slide 57 · Granulocyte colony-stimulating factor may be used

Granulocyte colony-stimulating factor (G-CSF) stimulates granulocyte production from marrow precursors.

Robbins mentions its use in selected settings such as myelosuppressive chemotherapy.

It acts on the production side of neutrophil homeostasis.

The source does not prescribe a universal indication or dosage for every cause.

G-CSF

Marrow precursor stimulation

Increased granulocyte production

Schematic

Slide 58 · Management principles are mechanism-linked

Immediate issue

Source-supported action

Biologic rationale

Signs of infection

Expeditious broad-spectrum antibiotics

Prevent progression of invasive infection

Selected post-chemotherapy neutropenia

G-CSF may be given

Stimulate granulocyte output

Unexplained persistent neutropenia

Determine the underlying mechanism

Different causes imply different marrow states

Diagnostic evaluation is a clinicopathologic teaching inference; This is not a treatment guideline.

Slide 59 · Case: Pancytopenia after chemotherapy

Following alkylating-agent treatment, a patient develops neutropenia with anemia and thrombocytopenia.

Which mechanism best explains the three-lineage pattern?

Generalized suppression of hematopoiesis.

Dose-related marrow toxicity affects granulocytic, erythroid, and platelet production.